Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies

NCT05100823 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
16
Enrollment
OTHER
Sponsor class

Stopped Enrolment period completed and sufficient number of enrolments to achieve study objectives

Conditions

Interventions

Sponsor

University Hospital, Montpellier

Collaborators